Clinical Trial Update: CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis [Phase 3]

View source ↗

Summary

A Phase 3 IV study in patients with anemia of chronic kidney disease on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• CKD-11101

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Anemia of Chronic Kidney Disease | Phase 3 | Status: COMPLETED